Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
Nose Neoplasms
×
Clear all
Filters
3
NCT02578641
2023-06-28
VANCE
Tessa Therapeutics
Phase 3
Completed
330 enrolled
18 charts